Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
5
×
san diego blog main
5
×
san diego top stories
san francisco blog main
san francisco top stories
spinal muscular atrophy
5
×
biogen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
fda
gene therapy
medicare
novartis
startups
vc
alexion pharmaceuticals
alzheimer's disease
cancer
cancer immunotherapy
celgene
What
bio
roundup
alzheimer’s
drug
gene
ipo
prices
remains
week
allogene
america
annual
assessed
attention
biogen
biotech
cancer
communities
companies
conference
continues
convoluted
crispr
crude
cutting
democrats
despite
different
diversity
dreams
edge
effects
encoded
esmo
europe
fail
germany
head
headaches
healthcare
Language
Current search:
biotech
×
" spinal muscular atrophy "
×
" new york top stories "
×
" san diego blog main "
×
@xconomy.com
5 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
